SelectQuote opened higher at $0.54, compared with its previous close of $0.51. In the last trading session, the stock traded between $0.49 and $0.54. It showed a downward intraday trend.
Return calculator
Time Period
An investment of $100 made 5 years ago in SelectQuote is now worth
$ 4.42
Resulting in a loss of
$ 95.58 (95.58%)
Invest with $1
Note: Past profits do not guarantee future returns.
Analyst Overview
Rating from 2 Analysts
Buy
50%
Hold
50%
Sell
0%
Markets Today
Today's Change
$-0.02 (-3.35%)
Day High
$0.54
Day Low
$0.49
Day Open
$0.54
Prev Close
$0.51
Volume
8,90,724
1W Return
0.62%
1M Return
38.81%
3M Return
-29.19%
6M Return
-52.88%
1Y Return
-69.38%
Fundamentals
Market Cap ($ Mn)
88
PE Ratio
-
PB Ratio
0.26
PEG Ratio
-
ROE
14.74%
ROCE
12.24%
EPS (TTM)
$-0.23
Investment Returns
1 Week
0.62%
1 Month
38.81%
3 Months
-29.19%
6 Months
-52.88%
9 Months
-44.32%
Financials
Quarterly
All values in $ Mn
345.1
Jun 25
328.8
Sep 25
537.1
Dec 25
430.9
Mar 26
321.7
Jun 26
280.0
Sep 26
Updates
25Aug
SelectQuote Q4FY26 Results: Revenue up 6% to $1.62 billion, EBITDA beats
Revenue rose 6% YoY to $1.62 billion in FY26, driven by 14% growth in Healthcare Services. Adjusted EBITDA reached $109 million, beating the $90-$100 million guidance range. Operating cash flow improved by $44 million year-over-year, aiding leverage reduction efforts. Healthcare Services exited FY26 on a nearly $50 million annual EBITDA run rate. FY27 revenue guidance is down 14% to $1.35-$1.45 billion as focus shifts to margin expansion.
2mo ago
25Aug
SelectQuote Q4 FY26 revenue misses estimates; net loss widens to $16.8 million
Q4 FY26 revenue fell 6.8% YoY to $321.7 million, missing estimates. Net loss widened to $16.8 million due to $6.0M warrant valuation charge. Adjusted EBITDA surged 340% to $11.9 million, signaling operational strength. Healthcare Services member base grew 1% to 109,039. FY27 guidance projects operating cash flow exceeding $60 million.
2mo ago
25Aug
SelectQuote FY27 sales guidance $1.35B-$1.45B vs $1.743B est
SelectQuote projects FY27 sales of $1.350 billion to $1.450 billion. Analyst estimate for FY27 sales was $1.743 billion. Guidance misses consensus by approximately $293 million to $393 million.
2mo ago
10Jun
Kuehn Law investigates SelectQuote over alleged fiduciary breaches
Kuehn Law is investigating SelectQuote for alleged fiduciary breaches, including misrepresenting plan comparisons and accepting illegal kickbacks. The firm claims these actions violated regulations and made positive statements about the company misleading. Investors who bought shares before September 9, 2020, are urged to contact Kuehn Law to enforce their rights.
